Medical News Podcast

In this episode, smoking one cigarette shortens life expectancy by an average of 20 minutes, with 17 minutes for men and 22 minutes for women, as shown by data from Britain. Also in this bpodcast, brief vigorous activity, like climbing stairs or carrying groceries, can lower cardiovascular risks, with just 3.4 minutes daily reducing major events by 45%. Finally, advances in cancer prevention, scre...

Andrew Kuykendall, MD and Rami Komrokji, MD discuss cytopenic myelofibrosis, reviewing how these patients typically present. They also cover mutational burden, specific treatment strategies, and prognosis in patients with the cytopenic phenotype.

Dr. Angela Fleischman and Dr. Gabriella Hobbs discussed two intriguing abstracts presented at the ASH 2024 Annual Meeting about emerging treatments for myelofibrosis. The first study, led by Dr. Lucia Massarova, explored the safety and preliminary efficacy of cord blood-derived CXCR4-enriched T-regulatory cells in patients with suboptimal response to ruxolitinib, showing minimal adverse events and...

Drs. Coombs and Shadman review CLL abstracts presented at the ASH 2024 annual meeting, including results from 2 early‑phase evaluations of BTK degraders and primary results of the ibrutinib combination cohort from the TRANSCEND CLL 004 study of the CAR T‑cell therapeutic, liso‑cel.

In this episode of the Peer Direct Specialist Spotlight, Gabriella Hobbs, MD and Angela Fleischman, MD, PhD discuss updates from the ASH 2024 annual meeting on emerging therapies for myelofibrosis, focusing on two agents: ilritracept and PXS-5505. Ilritracept, a modified ligand trap, showed promise in improving anemia, transfusion burden, spleen size, and symptoms, with data suggesting potential b...

A JAMA study identified factors linked to loss to follow-up in diabetic retinopathy and macular edema patients, including male gender, distance from care, and sociodemographic disparities. In Vietnam, six months of levofloxacin therapy showed a non-significant reduction in multidrug-resistant tuberculosis, emphasizing the balance between benefits and tolerability. Finally, Phase II trial showed pa...

Mazyar Shadman, MD, MPH and Catherine C. Coombs, MD review CLL abstracts presented at the ASH 2024 annual meeting, including results from the BRUIN CLL‑321 study of pirtobrutinib in relapsed or refractory CLL and the AMPLIFY study of first‑line acalabrutinib plus venetoclax.

Children raised on farms or with pets appear to have a lower risk of allergies due to early gut microbiota differentiation, as highlighted by a study from the Farm Flora Birth Cohort. Managing food allergies durin travel remains challenging, with a global survey showing inconsistent airline policies and unmet preventive measures. FDA trials indicate that resistance to Paxlovid in mild to moderate...

A Korean study found that anaphylaxis recurrence, affecting 15.6% of cases, is driven by socioeconomic factors and comorbidities, calling for targeted interventions. Australian data revealed a sharp rise in melanoma-related deaths for tumors 0.8–1.0 mm thick, suggesting a need for stricter monitoring and management for these patients. Lastly, the experimental drug BNC210 showed early promise in re...

Research from JAMA Dermatology suggests that ultra-processed foods may exacerbate psoriasis by promoting systemic inflammation and disrupting the gut microbiome, with potential benefits seen in dietary changes. A study presented at the Radiologic Society of North America revealed that transgender women face significantly higher injury rates, underscoring the need for better screening for intimate...

In the first episode of this two-part series, Elizabeth Kensinger, PhD and Andrew Budson, MD explore the science of memory, aging, and dementia. They discuss how memory encompasses a wide range of abilities and is influenced by factors like stress, lifestyle, and neurological health, highlighting differences in memory issues between younger adults, depression, and Alzheimer’s disease. The conversa...

John Mascarenhas, MD and Kathryn Johnson, DNP, MSc, FNP‑BC discuss the common signs and symptoms seen in patients with myelofibrosis and share insights into how they go about addressing them. They review anemia and splenomegaly, platelet-related symptoms of bleeding and thrombosis, and constitutional symptoms.

Dr. Mascarenhas and Kathryn Johnson review important considerations for referring physicians in clinical trials for myelofibrosis. They cover timing for referral, referral pathways, and appropriate patients, as well as assessments, monitoring, and even logistical considerations.

In 2023, measles cases rose 20% globally and immunization rates fell far below the 95% threshold needed to prevent outbreaks. A promising nasal spray therapy targeting neuroinflammation shows potential to delay Alzheimer’s progression by 10–15 years, according to a study leveraging neural stem cell-derived extracellular vesicles. Additionally, a phase 1 trial of neoantigen DNA vaccines in triple-n...

Drs. Clayton and Payne review the burden of PPD, highlighting the importance of early and effective treatment. They explore the impact of PPD on not only postpartum patients, but also on infants, families, and society as a whole.

Drs. Clayton and Payne review strategies for the identification and diagnosis of PPD. They discuss screening, diagnostic criteria, and differential diagnosis, among other topics.

In this podcast, a study from Ontario revealed that SGLT2 inhibitors, when combined with statins, were associated with a 25% lower risk of rhabdomyolysis compared to DPP4 inhibitors. A phase I trial at Washington University demonstrated promising outcomes for a neoantigen DNA vaccine aimed at preventing recurrence in triple-negative breast cancer (TNBC). Finally, intensive systolic blood pressure...

Drs. Payne and Clayton review in detail the management of patients with postpartum depression; discussing specific agents and classes of drugs, as well as nonpharmacological interventions and holistic and complementary approaches.

Drs. Siri and Jacobs discuss the biological treatment of patients with food allergies, reviewing currently available options, combination with immunotherapy, and other emerging therapies.

Drs. Siri and Jacobs discuss a typical case of a 4-year-old patient with peanut allergy, reviewing diagnostic and management strategies, as well as considerations such as age, IgE levels, oral food challenge, and current therapies.

Michael Putman, MD, MSci and Zachary Wallace, MD, MSc discuss a personalized approach to managing the treatment of patients with ANCA-associated vasculitis, including the role of ANCA type and titers and their impact on flare risk and treatment decisions.

NEJM reports on the safety of very early medication abortion, showing that initiating abortion medication before ultrasound confirmation is as effective and safe as the standard approach, reducing barriers in restricted settings. Another study highlighted the long-term survival impact of combining dabrafenib and trametinib for resected stage III melanoma patients with *BRAF* V600 mutations, noting...

Drs. Zachary Wallace and Michael Putman continue their induction therapy discussion in patients with ANCA-associated vasculitis, reviewing the use of glucocorticoids, avacopan, and plasma exchange.

Sami Diab, MD and Tejas Patil, MD continue their discussion about emerging treatments for HER2+ lung cancer, including data presented from DESTINY-Lung03, liquid biopsies, emerging resistance, and treatment sequencing..

Michael Putman, MD, MSci and Zachary Wallace, MD, MSc review induction chemotherapy in patients with ANCA-associated vasculitis, focusing on the use of cyclophosphamide and rituximab.